Log in
Iran: COVID-19 vaccine starts clinical trial Phase 2 and 3 of clinical trial for the first Iranian coronavirus vaccine, COVIran Barakat, began with two voluntary receivers.The first phase of COVIran Barakat test was carried out early in January and 56 volunteers at the age of 18-50 received two doses of the vaccine. Tehran Tehran Iran

Iran: COVID-19 vaccine starts clinical trial Phase 2 and 3 of clinical trial for the first Iranian coronavirus vaccine, COVIran Barakat, began with two voluntary receivers.The first phase of COVIran Barakat test was carried out early in January and 56 volunteers at the age of 18-50 received two doses of the vaccine. Tehran Tehran Iran

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Pacific Press Agency

Media ID:

Recording Date: Mar 15, 2021

Media Size: 4,851×3,238 Pixels

Iran: COVID-19 vaccine starts clinical trial Phase 2 and 3 of clinical trial for the first Iranian coronavirus vaccine, COVIran Barakat, began with two voluntary receivers.The first phase of COVIran Barakat test was carried out early in January and 56 volunteers at the age of 18-50 received two doses of the vaccine. Tehran Tehran Iran

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.